Media
Recent media coverage of BIND and its science:
BIND featured in Genetic Engineering and Biotechnolgoy News: Nanotechnology Enables Precise Cancer Targeting (GEN, July 2010)
BIND banks $12.4M round as lead program heads into PI (Fierce Biotech, June 2010)
Former J&J Group Chairman's Firm Backs BIND Biosciences in $12.4M Round (xconomy, June 2010)
Nanoparticle cancer therapy targets tumours and dodges immune system ((London)Timesonline, November 2009)
Stealthy Nanoparticles Attack Cancer Cells (Technology Review, November 2009)
BIND Biosciences: Emerging company profile (BioCentury, July 2008)
Where Investor Meets Scientist (Wall Street Journal, April 2008)
Bioworld article on BIND Biosciences (Bioworld, November 2007)
Betting on Nanotech Therapies (Wall Street Journal, September 2007)
Nano Bull's-eye (Mass High Tech, August 2007)
Top Five Nanotech Breakthroughs of 2006 (Forbes, December 2006)
Tumor-seeking Nanoparticles (NCI Cancer Bulletin, September 2006)
Cancer Smartbombs (ABC News, May 2006)
|
